← FDA DRUG APPROVALS

FDA NDA · NDA022470

NEXCEDE

Sponsor: NOVARTIS

APPLICATION
NDA022470
TYPE
NDA
ORIGINAL APPROVAL
2009-11-25
LATEST ACTION
2009-11-25
ROUTE
ORAL
DOSAGE FORM
FILM
MARKETING STATUS
Discontinued

Products

NEXCEDEDiscontinued
KETOPROFEN 12.5MG · FILM · ORAL

Approval history

2009-11-25Type 3 - New Dosage Form · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →